Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
jolly....now you're talking/ these are the insights that will make you very rich :)
am ..if the RNS tday, it will end up at £3 for sure :)....just buy/add and sit back and relax, long way to go yet. sold 10k sng today as promised to add to TILS on break. TILS science on Covid and recent results are too compeling to ignore , in addtion to their current pipeline
while kids play, rest and play...
In addition to the lastest Covid-19 development. As mentioned before said they are small fish playing big, and very disruptive to big biotec's/phama's with current pipeline of advanced developments in major diseases and big money market niches. Very overlooked and oversold company, even without Covid-19 development. Can see this traded to much higher multiples to current pps. enjoy.
Tiziana (TILS) focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology. In addition to milciclib, the Company is also developing Foralumab for liver diseases. Foralumab is the only fully human anti-CD3 mAbs in clinical development in the world. This compound has potential application in a wide range of autoimmune and inflammatory diseases, such as crohn's disease (CD), nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBS), ulcerative colitis, multiple sclerosis, type-1 diabetes (T1D), inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis, where modulation of a T-cell response is desirable.
85p buy, break over £1 will cuase a major storm, and the rquired re-rate to new highs. buy/ hold every single share.
only 15p and its over £1 - looking for £2 min in any case, pending patent/ fda testing plan submission.
Nice, sold 10k! to push into TILS. thanks. have 10k left. good luck to all here.
under £1 is very good buy - £1.70 will be tested, we will lead USA, we have to as TILS UK is the main common stock.
would nice to get Zak Mirs take.
Pikced this up - a recent note i picked up over the weekend by an independant review by a leading reseacher (IL-6):
''In the current situation with overwhelmed intensive care units and overcrowded emergency rooms, correct triage of patients in need of intensive care is crucial. Our study shows that IL-6 is an effective marker that might be able to predict upcoming respiratory failure with high accuracy and help physicians correctly allocate patients at an early stage''
Acknowledgement: We thank Oliver T. Keppler, the Task Force Corona at the University Hospital, LMU Munich and all CORKUM investigators as well as all health care workers for their outstanding service.
And this is what TILS management have said - both concure, and TILS has superior IL-6r.....(with 2 distinct advantages over Roche and Snofi - 2 big big names - hence why TILS issued a patent)
Really Like this - Alan Green must be happy and chilling.
We are adding Tiziana Life Sciences to the index following news the biotechnology company has developed investigational new technology to treat COVID-19 infections, which consists of direct delivery of anti-IL-6 receptor (anti-IL-6R) monoclonal antibodies (mAbs) into the lungs using a handheld inhaler or nebulizer.
Development of this novel technology is a step forward toward expediting development of TZLS-501, a fully human anti-interleukin-6 receptor (anti-IL6R) monoclonal antibody (mAb) for treatment of patients infected with COVID-19 (SARS-CoV-2) coronavirus.
UK now to lead USA.... the USA will scrample to make up their loses. TILS to retest high of 165/200 very soon, and hoefully break through this time. Will be good to get Zak Mirs take on this.
WHAT IS THE 'CYTOKINE STORM' KILLING COVID-19 PATIENTS?
Devastating lung inflammation triggered by the so-called 'cytokine storm' is thought to be what ultimately kills the sickest coronavirus patients.
Cytokines are a group of cells involved in the immune system's response to injury or infection.
They race to the site of a problem and signal to the body to send more immune cells to mount a defense against a foreign invader.
It's a crucial part of how the body heals itself - but when it goes haywire it can do lead to devastating damage.
The influx of immune cells causes inflammation which, when persistent, an go awry and start killing cells in the very tissues the immune system is trying to protect
When overabundant signalling cytokine cells stay switched 'on' for too long inflammation can continue out of control.
This inflammation overwhelms the lungs of coronavirus patients, sending them into respiratory failure an ultimately killing many of them if this inflammation can't be stemmed.
https://www.dailymail.co.uk/health/fb-8214619/WHAT-CYTOKINE-STORM-KILLING-COVID-19-PATIENTS.html
While kids play
Found this very compelling....and not many aim covid-19 stocks, have this kind of pipeline.
In addition to the lastest Covid-19 development. As mentioned before said TILS is small fish playing big, and very disruptive to big biotec's/phama's with current pipeline of advanced developments in major diseases and big money market niches. Very overlooked and oversold company, even without Covid-19 development. Can see this traded to much higher multiples to current pps. enjoy.
Tiziana (TILS) focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology. In addition to milciclib, the Company is also developing Foralumab for liver diseases. Foralumab is the only fully human anti-CD3 mAbs in clinical development in the world. This compound has potential application in a wide range of autoimmune and inflammatory diseases, such as crohn's disease (CD), nonalcoholic steatohepatitis (NASH), primary biliary cholangitis (PBS), ulcerative colitis, multiple sclerosis, type-1 diabetes (T1D), inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis, where modulation of a T-cell response is desirable.
Some info on what TILS is dealing with....
FDA quickly authorizes its second blood filtering device for COVID-19
Shortly after granting an emergency authorization to Terumo BCT’s blood filtering device for COVID-19, the FDA did the same for CytoSorbents’ system. Both are designed to strip out the immune system proteins that fuel the deadly cytokine-storm reactions associated with the disease.
Previously cleared for use in the European Union, the company’s CytoSorb purification system has been used to treat septic shock patients receiving intensive care, as well as those undergoing heart surgery or experiencing liver failure.
Now with the FDA’s blessing, the filters can be used in U.S. intensive care units for adults suffering from imminent respiratory failure, with acute lung injuries or severe COVID-19 disease.
Cytokine storms can cause severe inflammation, tissue damage and rapidly progressive shock, following a cascading release of white blood cells as the body overreacts to the coronavirus infection.
https://www.fiercebiotech.com/medtech/fda-quickly-authorizes-its-second-blood-filtering-device-for-covid-19
have good day.....might look to sell 1/4 at 222%...more research to come...
de-rampers out in full force.....told you they will come. and try to trick you out....lol. nice to see 7% up on nas yesterday.....looks like we could have good few days here.....expect some moves to shake off the weak.....same as what we saw at ncyt....:)
Technical Indicators...for those who like them :)
19 Indicators pointing to strong buy at these levels. see link below. My guess, we base around 1.20-1.50 in week until the next update, lets see. woudl be could pick up some more. May sell my remaining SNG holding on any uplift and add here into TILS, also have some AA not sure if they will do well tomorrow looking to sell at 25p. All looking to go into TILS, following extensive research this week. glta. always do you own dd and forget de-rampers/ one line crew. look for insights and follow real research etc.
https://www.tradingview.com/symbols/NASDAQ-TLSA/technicals/
https://novuscomms.com/2020/04/12/mail-on-sunday-market-watchlist-tiziana-life-sciences-tils/
just starting to get coverage.....for ealry birds
about TILS and FDA! :) here is it for you guys. For what's its worth.
BTW - up 8% af on NAS for any haters. just follow the research and the insights. do you own reseach as always.
Need patent to go through first, they are protecting intellecual rights - these guys like going against big biotech's, and really good to see they doing this, becuase there is risk there may well be Covid-20/21, and this patent will protect them in long term, as they modify their treatment. And scientist have said their may well be new strains of Covid. This is why I am very excited by TILS, becuase they are going for the real thing and thinking way ahead of the compition for Covid, even the big Bio's like Roche and Snofi (there are big names).
My gut feel is the management know they are sitting on gold mine, and moving very fast. All this in last 3 weeks, and getting cash with no problem/ hands down.
They are also in phase 2 - liver cancer which is beleived will disrupt big names. Little TILS is disrutive in their Niche. Soon they may just be common stock on NAS only, and cancel the ADR program. That will re-rate them to other cancer drug companies by default. Currently some confusion over the ponds for some. :)
Very intrigued by the menton of early stage in this research on il-6 , thats what TILS mentioned, to get to the infection direct in the lungs (IL-6) early to slow it down and kills the spread, allowing the person to take in (able to use) the oxygen and recover.